The medical laboratory is a supporting pillar of modern healthcare. Laboratory findings with analyses of blood, urine and other body fluids provide valuable insights from infection diagnostics and innovative screening procedures to therapy monitoring. Here you will find information on sample management, pre- and postanalytics, clinical chemistry, haematology and much more.
Asthma attacks induce mechanical forces that permanently alter airway tissue – independently of inflammation. New research used advanced lung-on-a-chip technology to show how this damage occurs.
Researchers have developed a new lab model to study BAP1-deficient melanomas, a rare type of melanoma that evade the immune system once they metastasize and are resistant to current immunotherapies.
A study from the University of Calgary shows that removing a single gene makes colon cancer cells a target for immunotherapy — a fundamental breakthrough.
Academic-industry partnerships are playing a crucial role in advancing computational pathology. At the Digital Pathology and AI Congress: Europe in London in December, Liron Pantanowitz outlined the benefits and risks of such collaborations – and why he believes the advantages outweigh the potential pitfalls.
Invasive fungal infections are silent, fast-moving, and notoriously hard to catch in time. The FUJIFILM Wako β-D-Glucan Test on the LIMUSAVE MT-7500 gives clinical laboratories a quantitative, LAL-based tool to detect (1→3)-β-D-glucan in serum or plasma – enabling earlier diagnosis where it matters most.
When the spinal cord is damaged, the resulting paralysis is usually considered permanent. Now, a new research approach using lab-grown organoid models suggests that it actually might be reversed.
A new study proposes a new antiviral strategy against SARS-CoV-2 based on a treatment that combines two complementary approaches, capable of attacking the virus simultaneously.
Microbiological cleanliness in laboratories demands far more than routine disinfection – it requires a comprehensive contamination control strategy from the very first design stage. At the Labs Expo trade fair in Poznań, Poland, industry experts Jerzy Kustra and Piotr Caban outlined the most common mistakes organisations make and how to avoid them.
Why does the same genetic mutation cause FCDII in some patients but not in others? Researchers developed organoids to model a brain malformation responsible for drug-resistant epilepsy in children.
Patient-derived organoids (PDOs), or tumoroids, for pediatric brain cancer show promise in helping researchers find new drugs and better understand the different responses of the tumor.
A new type of “breathing” lung organoid enables quantitative measurement of how easily the lung expands - and may provide a new way to study diseases such as pulmonary fibrosis.
A biomarker discovered in the cerebrospinal fluid could improve diagnosis of Parkinson's disease and dementia with Lewy bodies.
Bacterial infections can be difficult to distinguish from viral infections and inflammation, but a simple breath test may change that. This could reduce unnecessary antibiotic prescriptions.
Siemens Healthineers has announced the availability of two blood-based biomarker tests for research use: the Atellica IM Phosphorylated tau 217 (pTau217) and the Atellica IM Brain Derived Tau (BDTau) assays. Both are run on the Atellica Solution IM and Atellica CI Analyzers.
Glioblastoma is notorious for late diagnosis, rapid progression, resistance to treatment and its biological complexity. A new experimental method could help detect this deadly type of brain cancer.
On March 18–19, 2026, Poznań will host the fourth edition of the Laboratory Equipment and Technology Trade Fair, Labs Expo – an event combining presentations of modern technological solutions with an intensive, content-rich conference program. This year’s agenda has been designed for practitioners, including laboratory managers, QC and R&D specialists, metrologists, auditors,…
Coronaviruses can generate new variants capable of infecting humans after circulating in animal reservoirs. Researchers develop broad-spectrum antiviral drugs to curb the spread of these pathogens.
Using machine learning, researchers have trained an electronic nose to detect early signs of ovarian cancer in the blood. The method could eventually be used to find many different cancers.
Selecting the healthiest embryo is one of the most important steps in in‑vitro fertilization, yet it remains one of the most uncertain. A new type of hydrogel offers hope for more successful IVF.
